Terns Pharmaceuticals
TERN
TERN
246 hedge funds and large institutions have $4.95B invested in Terns Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 123 funds opening new positions, 72 increasing their positions, 42 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
76% more funds holding
Funds holding: 140 → 246 (+106)
71% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 42
34.81% more ownership
Funds ownership: 101.28% → 136.09% (+35%)
Holders
246
Holding in Top 10
19
Calls
$61.1M
Puts
$11.9M
Top Buyers
| 1 | +$104M | |
| 2 | +$101M | |
| 3 | +$78.1M | |
| 4 |
CLGM
Capitolis Liquid Global Markets
New York
|
+$70.4M |
| 5 |
Holocene Advisors
New York
|
+$64.1M |
Top Sellers
| 1 | -$183M | |
| 2 | -$155M | |
| 3 | -$125M | |
| 4 |
CC
Commodore Capital
New York
|
-$97.6M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$35.8M |
